Drug profile · INN
framycetin sulfate
SOFRAMYCIN
framycetin sulfate (SOFRAMYCIN) is a bacterial 70s ribosome inhibitor. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — framycetin sulfate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
framycetin sulfate (SOFRAMYCIN) is a bacterial 70s ribosome inhibitor. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN framycetin sulfate
Brand SOFRAMYCIN
Mechanism Bacterial 70S ribosome inhibitor
Target Bacterial 70S ribosome
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Related & competitor drugs
Frequently asked questions
What is framycetin sulfate?
framycetin sulfate (SOFRAMYCIN) is a bacterial 70s ribosome inhibitor. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for framycetin sulfate?
SOFRAMYCIN is a marketed brand name for framycetin sulfate. Check FDA Drugs@FDA for the current US label holder and prescribing information.